000 01761 a2200481 4500
005 20250513184103.0
264 0 _c19990616
008 199906s 0 0 eng d
022 _a0277-3732
024 7 _a10.1097/00000421-199906000-00009
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOkuno, S H
245 0 0 _aPhase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy.
_h[electronic resource]
260 _bAmerican journal of clinical oncology
_cJun 1999
300 _a258-61 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdministration, Oral
650 0 4 _aAdministration, Topical
650 0 4 _aAged
650 0 4 _aAntimetabolites, Antineoplastic
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aGlutamine
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMouthwashes
650 0 4 _aStomatitis
_xchemically induced
700 1 _aWoodhouse, C O
700 1 _aLoprinzi, C L
700 1 _aSloan, J A
700 1 _aLaVasseur, B I
700 1 _aClemens-Schutjer, D
700 1 _aSwan, D
700 1 _aAxvig, C
700 1 _aEbbert, L P
700 1 _aTirona, M R
700 1 _aMichalak, J C
700 1 _aPierson, N
773 0 _tAmerican journal of clinical oncology
_gvol. 22
_gno. 3
_gp. 258-61
856 4 0 _uhttps://doi.org/10.1097/00000421-199906000-00009
_zAvailable from publisher's website
999 _c10320908
_d10320908